Dr. Moreno-Sanz holds a PhD in Neurosciences from the Complutense University in Madrid, Spain, and is the author of more than 30 scientific articles and 3 patents describing the role of the endocannabinoid system at controlling pain initiation. He gained broad international experience with long-term fellowships in the Netherlands, Italy and the US, where he developed most of his career at the University of California, Irvine, where he discovered a new class of cannabinoid analgesics. In 2017, he founded Abagune Research, a cannabis advisory firm based in Spain, and served as a consultant to the US National Academies of Sciences in the report “The Health Effects of Cannabis and Cannabinoids”. In 2020, he joined Khiron Life Sciences Corp. as scientific and medical director for Europe.
The 2027 season
Meet speakers like Dr. in 2027
One flagship for the whole of European cannabis, and focused editions in the markets opening up next.
The Flagship
London 2027
23–24 June 2027 · Woolwich Works
Two days · Three stages · The Expo
General from £334VIP Experience £757
Emerging Markets
One market · One day · One room
No. 01Poland
Warsaw
3 March 2027 · Centrum Kreatywności Targowa
Delegate pass, all-inclusive · from £291Limited capacity
Reserve your pass →No. 02France
Paris
23 September 2027 · Hôtel de l'Industrie
Delegate pass, all-inclusive · from €252Limited capacity
Reserve your pass →